Showing results (71-80 of 915) with videos related to
Sort By:
Pageof 92
Clinical and Translational Science|November 18, 2022
The impact of genetic variability in urate transporters on oxypurinol pharmacokineticsHailemichael Z Hishe, Sophie L Stocker, Lisa K Stamp, et al.Plos One|February 1, 2022
Is repeat serum urate testing superior to a single test to predict incident gout over time?Sarah Stewart, Amanda Phipps-Green, Greg D Gamble, et al.The Journal of Rheumatology|February 3, 2020
Do Serum Urate-associated Genetic Variants Influence Gout Risk in People Taking Diuretics? Analysis of the UK BiobankRavi K Narang, Greg Gamble, Amanda J Phipps-Green, et al.Seminars in Arthritis and Rheumatism|June 14, 2014
Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of goutLisa K Stamp, Tony R Merriman, Murray L Barclay, et al.Seminars in Arthritis and Rheumatism|November 8, 2023
The statistical challenge of analysing changes in dual energy computed tomography (DECT) urate volumes in people with goutSarah Stewart, Greg Gamble, Anthony J Doyle, et al.Annals of the Rheumatic Diseases|August 13, 2014
Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20)Opetaia Aati, William J Taylor, Richard J Siegert, et al.Current Opinion in Rheumatology|December 8, 2016
Major unanswered questions in the clinical gout fieldLisa K StampCurrent Opinion in Rheumatology|January 1, 2014
Safety profile of anti-gout agents: an updateLisa K StampBritish Journal of Clinical Pharmacology|August 29, 2022
An allopurinol adherence tool using plasma oxypurinol concentrationsNatalia Smith-Diaz, Sophie L Stocker, Lisa K Stamp, et al.Arthritis Care & Research|September 23, 2024
Preferences for Tapering Biologic Disease-Modifying Antirheumatic Drugs Among People With Rheumatoid Arthritis: A Discrete Choice ExperimentSuz Jack Chan, Lisa K Stamp, Gareth J Treharne, et al.Pageof 92